Correspondence on 'Interleukin 6 receptor inhibition in primary Sjogren syndrome: a multicentre double-blind randomised controlled trial'

Research output: Contribution to journalComment/Letter to the editorAcademicpeer-review

6 Downloads (Pure)
Original languageEnglish
Pages (from-to)1
Number of pages1
JournalAnnals of the Rheumatic Diseases
DOIs
Publication statusE-pub ahead of print - 23-Mar-2021

Keywords

  • Sjogren's syndrome
  • therapeutics
  • outcome assessment
  • health care

Cite this